Does cellular iron dysregulation play a causative role in Parkinson's disease?

被引:110
作者
Kaur, D [1 ]
Andersen, J [1 ]
机构
[1] Buck Inst Aging Res, Novato, CA 94945 USA
关键词
Parkinson's disease; oxidative stress; iron; iron regulatory proteins; mitochondrial dysfunction; alpha-synuclein;
D O I
10.1016/j.arr.2004.01.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Selective dopaminergic cell loss in Parkinson's disease is correlated with increased levels of cellular iron. It is still hotly debated as to whether the increase in iron is an upstream event which acts to promote neurodegeneration via formation of oxidative stress or whether iron accumulates as a by-product of the neuronal cell loss. Here we review evidence for loss of iron homeostasis as a causative factor in disease-associated neurodegeneration and the primary players which may be involved. A series of recent studies suggest that iron regulatory proteins (IRPs) coordinate both cellular iron levels and energy metabolism, both of which are disrupted in Parkinson's disease (PD) and may in turn contribute to increased levels of oxidative stress associated with the disease. Iron has also been recently been implicated in promotion of alpha-synuclein aggregation either directly or via increasing levels of oxidative stress suggesting an important role for it in Lewy body formation, another important hallmark of the disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 343
页数:17
相关论文
共 99 条
[1]   Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[2]   T2 RELAXATION-TIME IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANTONINI, A ;
LEENDERS, KL ;
MEIER, D ;
OERTEL, WH ;
BOESIGER, P ;
ANLIKER, M .
NEUROLOGY, 1993, 43 (04) :697-700
[3]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[4]   DEGENERATION OF SUBSTANTIA-NIGRA IN CHRONIC PARKINSONS-DISEASE VISUALIZED BY TRANSCRANIAL COLOR-CODED REAL-TIME SONOGRAPHY [J].
BECKER, G ;
SEUFERT, J ;
BOGDAHN, U ;
REICHMANN, H ;
REINERS, K .
NEUROLOGY, 1995, 45 (01) :182-184
[5]   THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS [J].
BENSHACHAR, D ;
ESHEL, G ;
FINBERG, JPM ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) :1441-1444
[6]   Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy [J].
Berg, D ;
Jabs, B ;
Merschdorf, U ;
Beckmann, H ;
Becker, G .
BIOLOGICAL PSYCHIATRY, 2001, 50 (06) :463-467
[7]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[8]   Association study between iron-related genes polymorphisms and Parkinson's disease [J].
Borie, C ;
Gasparini, F ;
Verpillat, P ;
Bonnet, AM ;
Agid, Y ;
Hetet, G ;
Brice, A ;
Dürr, A ;
Grandchamp, B .
JOURNAL OF NEUROLOGY, 2002, 249 (07) :801-804
[9]  
Braak H, 2000, J NEUROL, V247, P3
[10]   Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia [J].
Bradley, JL ;
Blake, JC ;
Chamberlain, S ;
Thomas, PK ;
Cooper, JM ;
Schapira, AHV .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :275-282